Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Gossamer Bio, Inc. Common Stock | GOSS

AI Analysis of Gossamer Bio, Inc. Common Stock

Gossamer Bio had a rough day and is now down -6.59%. Investors weren't too impressed with the future outlook for the asset which caused some selling on weak demand.

The company isn't at an immediate support or resistance level that might be predictive. Gossamer Bio hasn't been looking too hot recently, some shareholders have been dumping shares over the last few months which has been driving prices down. In the past 3 months, the asset has lost -58.51 of it's value. So it's not looking great, I'd probably wait for a clearer support level before coming in. GOSS might find some support at the 0.1927 level, buyers might push the price back up from here. But it's not very clear what will happen.


Last analyzed on 2026-07-23

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-